Therapeutic switch adverse event reports solicited by FDA in Internet notice.
Executive Summary
THERAPEUTIC SWITCH-RELATED ADVERSE EVENT REPORTS REQUESTED BY FDA in a statement issued by the agency's Division of Drug Marketing, Advertising & Communications on March 3. "We are requesting the assistance of health professionals who are aware of any adverse consequences of therapeutic switches to report them through FDA's MedWatch reporting system as expeditiously as possible," the agency said. The request was posted on FDA's Internet site.